Compound ID | 35
hBD-1
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | The 1:1 hBD-1/hBD-2 combination showed maximum effectiveness against varying gram negative and positive bacterium including E. coli, S. aureus,S. Typhi and S. enterica |
| Combined with other compounds: | Yes |
| Institute where first reported: | Division of Gene Function and Regulation, Institute of Life Sciences, Department of Biotechnology, Government of India, Bhubaneswar, Odisha, India |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/protein/P60022 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249419/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.